References
- Al Shaikh A, Daftardar H, Alghamdi AA, Jamjoom M, Awidah S, Ahmed ME, et al. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center. Acta Biomed. 2020;91(1):29-40. DOI: 10.23750/abm.v91i1.9182
- Yuan J, Du Z, Wu Z, Yang Y, Cheng X, Liu X, et al. A Novel Diagnostic Predictive Model for Idiopathic Short Stature in Children. Front Endocrinol. 2021;12:721812. DOI: 10.3389/fendo.2021.721812
- Savage MO, Storr HL. GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy. Front Endocrinol. 2021;12:781044. DOI: 10.3389/fendo.2021.781044
- Sasanuma H, Nakata M, Parmila K, Nakae J, Yada T. PDK1-FoxO1 pathway in AgRP neurons of arcuate nucleus promotes bone formation via GHRH-GH-IGF1 axis. Mol Metab. 2017;6(5):428-39. DOI: 10.1016/j.molmet.2017.02.003
- Recinella L, Orlando G, Ferrante C, Chiavaroli A, Brunetti L, Leone S. Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front Physiol. 2020;11:578966. DOI: 10.3389/fphys.2020.578966
- Zhu Y, Gu Z, Shi J, Chen C, Xu H, Lu Q. Vaspin Attenuates Atrial Abnormalities by Promoting ULK1/FUNDC1-Mediated Mitophagy. Oxid Med Cell Longev. 2022;2022:3187463. DOI: 10.1155/2022/3187463
- Koutaki D, Michos A, Bacopoulou F, Charmandari E. The Emerging Role of Sfrp5 and Wnt5a in the Pathogenesis of Obesity: Implications for a Healthy Diet and Lifestyle. Nutrients. 2021;13(7):2459. DOI: 10.3390/nu13072459
- Rogol AD, Hayden GF. Etiologies and early diagnosis of short stature and growth failure in children and adolescents. J Pediatr. 2014;164(5 Suppl):S1-S14.e6. DOI: 10.1016/j.jpeds.2014.02.027
- Zhang S, Liu L, Wu Z, Liu G, Ma Z, Shen X. The skeletal development standards of hand and wrist for Chinese children-China 05 I. TW3-C RUS, TW3-C carpal, and RUS-CHN methods. Chin J Sports Med. 2006;15:509-16.
- Decker R, Albertsson-Wikland K, Kriström B, Nierop AF, Gustafsson J, Bosaeus I, et al. Metabolic outcome of GH treatment in prepubertal short children with and without classical GH deficiency. Clin Endocrinol. 2010;73(3):346-54. DOI: 10.1111/j.1365-2265.2010.03812.x
- Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB, et al. Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr. 2016;86(6):361-97. DOI: 10.1159/000452150
- Lazar L, Levy S, Oron T, Meyerovitch J, de Vries L, Shalitin S, et al. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS. J Clin Endocrinol Metab. 2019;104(8):3287-95. DOI: 10.1210/jc.2019-00233
- Sun F, Chao L, Zhang J, Pan X. Exercise combined with lysineinositol vitamin B12 promotes height growth in children with idiopathic short stature. Growth Horm IGF Res. 2023;69:101535. DOI: 10.1016/j.ghir.2023.101535
- Willems M, Amouroux C, Barat-Houari M, Salles JP, Edouard T. Exploring the genetic causes of isolated short stature. What has happened to idiopathic short stature? Arch Pediatr. 2022;28(8):28/8S27-32. DOI: 10.1016/S0929-693X(22)00040-9
- List EO, Berryman DE, Buchman M, Jensen EA, Funk K, Duran-Ortiz S, et al. GH Knockout Mice Have Increased Subcutaneous Adipose Tissue With Decreased Fibrosis and Enhanced Insulin Sensitivity. Endocrinology. 2019;60:1743-56. DOI: 10.1210/en.2019-00167
- Wu H, Peng Z, Xu Y, Sheng Z, Liu Y, Liao Y, et al. Engineered adipose-derived stem cells with IGF-1-modified mRNA ameliorates osteoarthritis development. Stem Cell Res Ther. 2022;13(1):19. DOI: 10.1186/s13287-021-02695-x
- List EO, Berryman DE, Funk K, Gosney ES, Jara A, Kelder B, et al. The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted micet. Mol Endocrinol. 2013;27(3):524-35. DOI: 10.1210/me.2012-1330
- Koizumi M, Ida S, Shoji Y, Nishimoto Y, Etani Y, Kawai M. Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome. Endocr J. 2018;65(11):1127-37. DOI: 10.1507/endocrj.EJ18-0107
- Hu Z, Deng H, Qu H. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance. Diabetes Res Clin Pract. 2013;99(3):391-5. DOI: 10.1016/j.diabres.2012.11.026
- Carstensen-Kirberg M, Röhrig K, Niersmann C, Ouwens DM, Belgardt BF, Roden M, et al. Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E.PLoS One. 2019;14(3):e0213650. DOI: 10.1371/journal.pone.0213650
- Rydzewska M, Nikołajuk A, Matulewicz N, Stefanowicz M, Karczewska-Kupczewska M. Serum secreted frizzled-related protein 5 in relation to insulin sensitivity and its regulation by insulin and free fatty acids. Endocrine. 2021;74(2):300-7. DOI: 10.1007/s12020-021-02793-z
- Witkowska-Sędek E, Rumińska M, Majcher A, Pyrżak B. Gender-Dependent Growth and Insulin-Like Growth Factor-1 Responses to Growth Hormone Therapy in Prepubertal Growth Hormone-Deficient Children. Adv Exp Med Biol. 2019;1133:65-73. DOI: 10.1007/5584_2018_284
- Jaikanth C, Gurumurthy P, Indhumathi T, Cherian KM. Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways. Minerva Endocrinol. 2017;42(3):280-9. DOI: 10.23736/S0391-1977.16.02232-X
- Chen H, He Y, Wu D, Dai G, Zhao C, Huang W, et al. Bone marrow sFRP5 level is negatively associated with bone formation markers. Osteoporos Int. 2017;28(4):1305-11. DOI: 10.1007/s00198-016-3873-3
- Nicholson T, Church C, Tsintzas K, Jones R, Breen L, Davis ET, et al. Vaspin promotes insulin sensitivity of elderly muscle and is upregulated in obesity. J Endocrinol. 2019;241:31-43. DOI: 10.1530/JOE-18-0528
- Kurowska P, Mlyczyńska E, Barbe A, Staub C, Gregoraszczuk E, Dupont J, et al. Vaspin in the pig ovarian follicles: expression and regulation by different hormones. Reproduction. 2019;158(2):135-46. DOI: 10.1530/REP-19-0034
- Tarabeih N, Kalinkovich A, Shalata A, Livshits G. Circulating Levels of Visceral Adipose Tissue-Derived Serine Protease Inhibitor (Vaspin) Appear as a Marker of Musculoskeletal Pain Disability. Diagnostics. 2020;10(10):797. DOI: 10.3390/diagnostics10100797